Cargando…
International Impact of COVID-19 on the Diagnosis of Heart Disease
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified. OBJECTIVES: Th...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836433/ https://www.ncbi.nlm.nih.gov/pubmed/33446311 http://dx.doi.org/10.1016/j.jacc.2020.10.054 |
_version_ | 1783642748671229952 |
---|---|
author | Einstein, Andrew J. Shaw, Leslee J. Hirschfeld, Cole Williams, Michelle C. Villines, Todd C. Better, Nathan Vitola, Joao V. Cerci, Rodrigo Dorbala, Sharmila Raggi, Paolo Choi, Andrew D. Lu, Bin Sinitsyn, Valentin Sergienko, Vladimir Kudo, Takashi Nørgaard, Bjarne Linde Maurovich-Horvat, Pál Campisi, Roxana Milan, Elisa Louw, Lizette Allam, Adel H. Bhatia, Mona Malkovskiy, Eli Goebel, Benjamin Cohen, Yosef Randazzo, Michael Narula, Jagat Pascual, Thomas N.B. Pynda, Yaroslav Dondi, Maurizio Paez, Diana |
author_facet | Einstein, Andrew J. Shaw, Leslee J. Hirschfeld, Cole Williams, Michelle C. Villines, Todd C. Better, Nathan Vitola, Joao V. Cerci, Rodrigo Dorbala, Sharmila Raggi, Paolo Choi, Andrew D. Lu, Bin Sinitsyn, Valentin Sergienko, Vladimir Kudo, Takashi Nørgaard, Bjarne Linde Maurovich-Horvat, Pál Campisi, Roxana Milan, Elisa Louw, Lizette Allam, Adel H. Bhatia, Mona Malkovskiy, Eli Goebel, Benjamin Cohen, Yosef Randazzo, Michael Narula, Jagat Pascual, Thomas N.B. Pynda, Yaroslav Dondi, Maurizio Paez, Diana |
author_sort | Einstein, Andrew J. |
collection | PubMed |
description | BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified. OBJECTIVES: The study sought to assess COVID-19’s impact on global cardiovascular diagnostic procedural volumes and safety practices. METHODS: The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March and April 2020 and compared with those from March 2019. Availability of personal protective equipment and pandemic-related testing practice changes were ascertained. RESULTS: Surveys were submitted from 909 inpatient and outpatient centers performing cardiac diagnostic procedures, in 108 countries. Procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Transthoracic echocardiography decreased by 59%, transesophageal echocardiography 76%, and stress tests 78%, which varied between stress modalities. Coronary angiography (invasive or computed tomography) decreased 55% (p < 0.001 for each procedure). In multivariable regression, significantly greater reduction in procedures occurred for centers in countries with lower gross domestic product. Location in a low-income and lower–middle-income country was associated with an additional 22% reduction in cardiac procedures and less availability of personal protective equipment and telehealth. CONCLUSIONS: COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the globe, especially affecting the world’s economically challenged. Further study of cardiovascular outcomes and COVID-19–related changes in care delivery is warranted. |
format | Online Article Text |
id | pubmed-7836433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78364332021-01-26 International Impact of COVID-19 on the Diagnosis of Heart Disease Einstein, Andrew J. Shaw, Leslee J. Hirschfeld, Cole Williams, Michelle C. Villines, Todd C. Better, Nathan Vitola, Joao V. Cerci, Rodrigo Dorbala, Sharmila Raggi, Paolo Choi, Andrew D. Lu, Bin Sinitsyn, Valentin Sergienko, Vladimir Kudo, Takashi Nørgaard, Bjarne Linde Maurovich-Horvat, Pál Campisi, Roxana Milan, Elisa Louw, Lizette Allam, Adel H. Bhatia, Mona Malkovskiy, Eli Goebel, Benjamin Cohen, Yosef Randazzo, Michael Narula, Jagat Pascual, Thomas N.B. Pynda, Yaroslav Dondi, Maurizio Paez, Diana J Am Coll Cardiol Original Investigation BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified. OBJECTIVES: The study sought to assess COVID-19’s impact on global cardiovascular diagnostic procedural volumes and safety practices. METHODS: The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March and April 2020 and compared with those from March 2019. Availability of personal protective equipment and pandemic-related testing practice changes were ascertained. RESULTS: Surveys were submitted from 909 inpatient and outpatient centers performing cardiac diagnostic procedures, in 108 countries. Procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Transthoracic echocardiography decreased by 59%, transesophageal echocardiography 76%, and stress tests 78%, which varied between stress modalities. Coronary angiography (invasive or computed tomography) decreased 55% (p < 0.001 for each procedure). In multivariable regression, significantly greater reduction in procedures occurred for centers in countries with lower gross domestic product. Location in a low-income and lower–middle-income country was associated with an additional 22% reduction in cardiac procedures and less availability of personal protective equipment and telehealth. CONCLUSIONS: COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the globe, especially affecting the world’s economically challenged. Further study of cardiovascular outcomes and COVID-19–related changes in care delivery is warranted. The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. 2021-01-19 2021-01-11 /pmc/articles/PMC7836433/ /pubmed/33446311 http://dx.doi.org/10.1016/j.jacc.2020.10.054 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Investigation Einstein, Andrew J. Shaw, Leslee J. Hirschfeld, Cole Williams, Michelle C. Villines, Todd C. Better, Nathan Vitola, Joao V. Cerci, Rodrigo Dorbala, Sharmila Raggi, Paolo Choi, Andrew D. Lu, Bin Sinitsyn, Valentin Sergienko, Vladimir Kudo, Takashi Nørgaard, Bjarne Linde Maurovich-Horvat, Pál Campisi, Roxana Milan, Elisa Louw, Lizette Allam, Adel H. Bhatia, Mona Malkovskiy, Eli Goebel, Benjamin Cohen, Yosef Randazzo, Michael Narula, Jagat Pascual, Thomas N.B. Pynda, Yaroslav Dondi, Maurizio Paez, Diana International Impact of COVID-19 on the Diagnosis of Heart Disease |
title | International Impact of COVID-19 on the Diagnosis of Heart Disease |
title_full | International Impact of COVID-19 on the Diagnosis of Heart Disease |
title_fullStr | International Impact of COVID-19 on the Diagnosis of Heart Disease |
title_full_unstemmed | International Impact of COVID-19 on the Diagnosis of Heart Disease |
title_short | International Impact of COVID-19 on the Diagnosis of Heart Disease |
title_sort | international impact of covid-19 on the diagnosis of heart disease |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836433/ https://www.ncbi.nlm.nih.gov/pubmed/33446311 http://dx.doi.org/10.1016/j.jacc.2020.10.054 |
work_keys_str_mv | AT einsteinandrewj internationalimpactofcovid19onthediagnosisofheartdisease AT shawlesleej internationalimpactofcovid19onthediagnosisofheartdisease AT hirschfeldcole internationalimpactofcovid19onthediagnosisofheartdisease AT williamsmichellec internationalimpactofcovid19onthediagnosisofheartdisease AT villinestoddc internationalimpactofcovid19onthediagnosisofheartdisease AT betternathan internationalimpactofcovid19onthediagnosisofheartdisease AT vitolajoaov internationalimpactofcovid19onthediagnosisofheartdisease AT cercirodrigo internationalimpactofcovid19onthediagnosisofheartdisease AT dorbalasharmila internationalimpactofcovid19onthediagnosisofheartdisease AT raggipaolo internationalimpactofcovid19onthediagnosisofheartdisease AT choiandrewd internationalimpactofcovid19onthediagnosisofheartdisease AT lubin internationalimpactofcovid19onthediagnosisofheartdisease AT sinitsynvalentin internationalimpactofcovid19onthediagnosisofheartdisease AT sergienkovladimir internationalimpactofcovid19onthediagnosisofheartdisease AT kudotakashi internationalimpactofcovid19onthediagnosisofheartdisease AT nørgaardbjarnelinde internationalimpactofcovid19onthediagnosisofheartdisease AT maurovichhorvatpal internationalimpactofcovid19onthediagnosisofheartdisease AT campisiroxana internationalimpactofcovid19onthediagnosisofheartdisease AT milanelisa internationalimpactofcovid19onthediagnosisofheartdisease AT louwlizette internationalimpactofcovid19onthediagnosisofheartdisease AT allamadelh internationalimpactofcovid19onthediagnosisofheartdisease AT bhatiamona internationalimpactofcovid19onthediagnosisofheartdisease AT malkovskiyeli internationalimpactofcovid19onthediagnosisofheartdisease AT goebelbenjamin internationalimpactofcovid19onthediagnosisofheartdisease AT cohenyosef internationalimpactofcovid19onthediagnosisofheartdisease AT randazzomichael internationalimpactofcovid19onthediagnosisofheartdisease AT narulajagat internationalimpactofcovid19onthediagnosisofheartdisease AT pascualthomasnb internationalimpactofcovid19onthediagnosisofheartdisease AT pyndayaroslav internationalimpactofcovid19onthediagnosisofheartdisease AT dondimaurizio internationalimpactofcovid19onthediagnosisofheartdisease AT paezdiana internationalimpactofcovid19onthediagnosisofheartdisease AT internationalimpactofcovid19onthediagnosisofheartdisease AT internationalimpactofcovid19onthediagnosisofheartdisease |